Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Andrew Gengos Insider Profile
4 Followers
Andrew Gengos, President & CEO, Director at ImmunoCellular Therapeutics, holds 238.33K shares in ImmunoCellular Therapeutics (Ticker: IMUC), holds ― shares in Synlogic (Ticker: SYBX), holds ― shares in Cyteir Therapeutics (Ticker: CYT).
Andrew Gengos ImmunoCellular Therapeutics (IMUC)President & CEO, Director
ImmunoCellular Therapeutics (IMUC)
President & CEO, Director
Ranked #67,607 out of 100,202 Corporate Insiders
Profitable Transactions
1 out of 6 Profitable Transactions
Average Return
-9.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Andrew Gengos holds in companies
Most Profitable Insider Trade
The most profitable trade made by Andrew Gengos
Andrew Gengos's Trading History
ImmunoCellular Therapeutics
Feb 13, 2017
President & CEO, Director
Uninformative Sell
6.73K
$40.04K
Synlogic
―
COO
―
―
Cyteir Therapeutics
―
―
―
―
Athira Pharma
Sep 05, 2024
CFO and Chief Business Officer
Uninformative Buy
13.40K
$56.18K
List of latest transactions for each holding click on a transaction to see Andrew Gengos's performance on stock
You May Also Like
Andrew Gengos insider profile FAQ
What is the percentage of profitable transactions made by Andrew Gengos?
The percentage of profitable transactions made by Andrew Gengos is 17%.
What is the average return per transaction made by Andrew Gengos?
The average return per transaction made by Andrew Gengos is -9.20%.
What stocks does Andrew Gengos hold?
Andrew Gengos holds: IMUC, SYBX, CYT, ATHA stocks.
What was Andrew Gengos’s latest transaction?
Andrew Gengos latest transaction was an Uninformative Sell of $6.73K.
What was Andrew Gengos's most profitable transaction?
Andrew Gengos’s most profitable transaction was an Informative Sell of ATHA stock on January 8, 2024. The return on the trade was 81.80%.
What is Andrew Gengos's role in ImmunoCellular Therapeutics?
Andrew Gengos's role in ImmunoCellular Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.